Related Experiment Videos

[Generalized herpesvirus infection with severe consumption coagulopathy in a newborn infant]

Kinderarztliche Praxis
|January 1, 1989
PubMed

Insights

Acyclovir effectively treated disseminated neonatal herpes simplex virus (HSV) infection, controlling bleeding and enabling normal development. This highlights Acyclovir's potent antiviral action against HSV in newborns.

Area of Science:

  • Virology
  • Neonatal Medicine
  • Pharmacology

Background:

  • Neonatal herpes simplex virus (HSV) infection can lead to severe disseminated disease.
  • Consumption coagulopathy and bleeding are critical complications in neonatal HSV.
  • Early diagnosis and effective antiviral therapy are crucial for infant survival.

Observation:

  • A mature newborn presented with disseminated HSV infection symptoms on the 6th day of life.
  • Severe bleeding occurred due to consumption coagulopathy during the infection.
  • Treatment with Acyclovir and fibrinogen replacement controlled bleeding.

Findings:

  • Acyclovir demonstrated significant virostatic efficacy, inhibiting HSV DNA replication.
  • The infant survived with normal psychologic and motor development post-treatment.
  • Diagnosis was confirmed by HSV detection in blister fluid, cerebrospinal fluid, and serology.

Implications:

  • Acyclovir is a highly effective treatment for severe neonatal HSV infections.
  • Selective inhibition of viral DNA polymerase by Acyclovir is key to its efficacy.
  • Prompt management of coagulopathy alongside antiviral therapy improves outcomes in neonatal HSV.

Related Concept Videos